Learn more →
Back to Expert Scholars
melanoma / melanomaMelanoma Immunotherapy

Richard Scolyer

理查德·斯科利尔

MBBS, MD

🏢University of Sydney / Royal Prince Alfred Hospital(悉尼大学/皇家阿尔弗雷德王子医院)🌐Australia

Co-Medical Director, Melanoma Institute Australia; Professor of Melanoma Pathology澳大利亚黑色素瘤研究所联合医疗主任;黑色素瘤病理学教授

70
h-index
3
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Richard Scolyer is the world's foremost melanoma pathologist and co-medical director of Melanoma Institute Australia. His expertise in melanoma histopathology, staging, and multidisciplinary care has been pivotal in developing prognostic tools and neoadjuvant immunotherapy trials.

Share:

🧪Research Fields 研究领域

Melanoma Pathology黑色素瘤病理学
Multidisciplinary Oncology多学科肿瘤学
Neoadjuvant Immunotherapy新辅助免疫治疗
Melanoma Diagnosis黑色素瘤诊断

🎓Key Contributions 主要贡献

Melanoma Pathology and Staging

Advanced histopathological classification and staging of melanoma, contributing to AJCC staging revisions that improved prognostication for patients with primary and metastatic melanoma.

Pathologic Response Assessment

Developed standardized pathologic response criteria for neoadjuvant immunotherapy trials in melanoma, enabling accurate assessment of treatment efficacy and correlation with survival outcomes.

Brain Metastasis Immunotherapy

Contributed to clinical trials and pathologic characterization of melanoma brain metastases treated with checkpoint inhibitors, demonstrating intracranial activity of combination immunotherapy.

Representative Works 代表性著作

[1]

Pathological Features of Melanoma Tumors after Treatment with Neoadjuvant Checkpoint Inhibitors

Annals of Oncology (2019)

Defined pathologic response criteria for neoadjuvant immunotherapy critical for trial endpoint standardization.

[2]

Long-Term Outcome Following Targeted Therapy or Immunotherapy in Melanoma Brain Metastases

Journal of Clinical Oncology (2021)

Characterized survival outcomes and pathologic features of brain metastases responding to modern systemic therapy.

[3]

Advances in Melanoma Pathology: Clinical Implications and Future Directions

Nature Reviews Clinical Oncology (2020)

Comprehensive review of advances in melanoma pathology, diagnostics, and their impact on clinical management.

🏆Awards & Recognition 奖项与荣誉

🏆Australian of the Year NSW (co-winner 2024)
🏆Royal College of Pathologists of Australasia (RCPA) Medal
🏆International Melanoma Research Congress Award
🏆Cancer Institute NSW Premier's Award for Outstanding Cancer Research

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 理查德·斯科利尔 的研究动态

Follow Richard Scolyer's research updates

留下邮箱,当我们发布与 Richard Scolyer(University of Sydney / Royal Prince Alfred Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment